Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Nivolumab Intravenous
Determining the interaction of Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Nivolumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: nivolumab
Brand name: Opdivo
Synonyms: Nivolumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Nizatidine
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Nizatidine Capsules and Tablets
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Nizatidine Oral Solution
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Nizatidine Solution
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Nizoral
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-No Doz Maximum Strength
- Nivolumab Intravenous-Kitabis Pak
- Nivolumab Intravenous-Kitabis Pak inhalation
- Nivolumab Intravenous-Klofensaid II
- Nivolumab Intravenous-Klonopin
- Nivolumab Intravenous-Klonopin Wafer
- Nivolumab Intravenous-Klonopin Wafers